1. Search Result

Search Result

Results for "2097132-93-7" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-112301A
    trans-Pralsetinib

    trans-BLU-667

    RET Cancer
    trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129.